Ticker > Company >

Par Drugs & Chem. share price

Par Drugs And Chemicals Ltd.

NSE: PAR SECTOR: Chemicals  25k   141   8

299.20
+0.20 (0.07%)
NSE: 07 Nov 03:55 PM

Price Summary

Today's High

₹ 302.4

Today's Low

₹ 290.05

52 Week High

₹ 325

52 Week Low

₹ 190.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

368.15 Cr.

Enterprise Value

331.5 Cr.

No. of Shares

1.23 Cr.

P/E

20.15

P/B

3.8

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  78.64

CASH

36.65 Cr.

DEBT

0 Cr.

Promoter Holding

73.37 %

EPS (TTM)

₹  14.85

Sales Growth

-0.11%

ROE

18.49 %

ROCE

25.02%

Profit Growth

27.94 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-0.11%
3 Year16.33%
5 Year15.6%

Profit Growth

1 Year27.94%
3 Year7.69%
5 Year42.01%

ROE%

1 Year18.49%
3 Year17.41%
5 Year18.18%

ROCE %

1 Year25.02%
3 Year23.36%
5 Year22.86%

Debt/Equity

0

Price to Cash Flow

18.18

Interest Cover Ratio

183.2278

CFO/PAT (5 Yr. Avg.)

1.18654524459774

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.37 0.00
Jun 2024 74.21 0.00
Mar 2024 74.21 0.00
Dec 2023 74.21 0.00
Sep 2023 74.21 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 16.3307725955812% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 23.3591469994998% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 183.2278.
  • Company’s PEG ratio is 0.721268444409247.
  • The company has an efficient Cash Conversion Cycle of -4.163 days.
  • Company has a healthy liquidity position with current ratio of 4.7932.
  • The company has a good cash flow management; CFO/PAT stands at 1.18654524459774.
  • The company has a high promoter holding of 73.37%.

 Limitations

  • The company has shown a poor profit growth of 7.68956324491927% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 25.89 24 22.82 22.61 34.66
Total Expenditure 18.53 18.77 16.73 18.37 23.25
Operating Profit 7.36 5.23 6.09 4.24 11.41
Other Income 0.05 0.23 -0.05 0.07 1.02
Interest 0.03 0.02 0.05 0.02 0.03
Depreciation 0.85 0.87 0.89 0.9 0.91
Exceptional Items 0 0 0 0 0
Profit Before Tax 6.54 4.57 5.11 3.38 11.49
Tax 1.65 1.15 1.39 0.85 2.89
Profit After Tax 4.89 3.42 3.72 2.53 8.6
Adjusted EPS (Rs) 3.97 2.78 3.02 2.06 6.99

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 55.85 60.75 75.07 95.75 95.64
Total Expenditure 46.41 44.74 58.82 77.54 72.82
Operating Profit 9.44 16.01 16.25 18.21 22.82
Other Income 0.1 0.19 0.18 0.24 0.24
Interest 0.79 0.64 0.45 0.13 0.11
Depreciation 2.76 2.82 3.28 3.23 3.44
Exceptional Items 0 1.99 0 0 0
Profit Before Tax 5.99 14.73 12.7 15.08 19.52
Tax 1.23 3.11 3.49 3.75 5.02
Net Profit 4.76 11.61 9.21 11.33 14.5
Adjusted EPS (Rs.) 3.87 9.44 7.49 9.21 11.79

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.15 6.15 12.3 12.3 12.3
Total Reserves 34.46 46.06 47.57 58.93 73.33
Borrowings 4.62 4.39 0 0 0
Other N/C liabilities 4.04 3.8 3.96 3.64 3.54
Current liabilities 10.84 15.98 14.86 13.99 12.44
Total Liabilities 60.12 76.38 78.69 88.87 101.61
Assets
Net Block 34.4 29.91 34.1 38.45 41.31
Capital WIP 0.74 4.52 0.25 0.25 0.03
Intangible WIP 0 0 0 0 0
Investments 0.06 0.01 0.01 0.01 0.01
Loans & Advances 0.71 0.76 0.76 0.73 0.64
Other N/C Assets 0 0 0 0 0
Current Assets 24.22 41.19 43.56 49.44 59.62
Total Assets 60.12 76.38 78.69 88.87 101.61
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 5.99 14.73 12.7 15.08 19.52
Adjustment 3.41 1.29 3.46 3.02 3.09
Changes in Assets & Liabilities -0.85 -0.34 -5.43 -0.46 2
Tax Paid -0.85 -3.59 -3.12 -4.26 -4.36
Operating Cash Flow 7.69 12.09 7.62 13.38 20.25
Investing Cash Flow -1.46 0.05 -3.02 -7.34 -5.84
Financing Cash Flow 1.11 1.65 -9.55 0 0
Net Cash Flow 7.35 13.78 -4.96 6.04 14.41

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 74.21 74.21 74.21 74.21 73.37
falgun vallabhbhai savani... 21.50 21.50 21.50 21.50 21.50
ghanshayambhai b savani 6.52 6.52 6.52 6.52 6.52
jignesh vallabhbhai savan... 21.88 21.88 21.88 21.88 21.88
saritaben vallabhbhai sav... 21.32 21.32 21.32 21.32 20.48
savani nayna jignesh 1.54 1.54 1.54 1.54 1.54
shilpaben falgun savani 1.54 1.44 1.44 1.44 1.44
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 25.79 25.79 25.79 25.79 26.63
jainam broking limited - - - 1.47 1.75
llp 0.24 0.37 0.38 1.35 0.10
vardhilal shivrambhai tha... - - - 1.54 1.54

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Par Drugs & Chem. - Quaterly Results 22 Oct, 12:00 PM Par Drugs & Chem. - Quaterly Results 22 Oct, 12:00 PM Par Drugs & Chem. - Quaterly Results 22 Oct, 12:00 PM Par Drugs & Chem. - Quaterly Results 3 Aug, 12:00 PM Par Drugs & Chem. - Quaterly Results 3 Aug, 12:00 PM Par Drugs & Chem. - Quaterly Results 3 Aug, 12:00 PM Par Drugs & Chem. - Quaterly Results 9 May, 12:00 PM Par Drugs & Chem. - Quaterly Results 9 May, 12:00 PM Par Drugs & Chem. - Quaterly Results 16 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 16 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 28 Oct, 12:00 PM Par Drugs & Chem. - Quaterly Results 28 Oct, 12:00 PM Par Drugs & Chem. - Quaterly Results 28 Oct, 12:00 PM Par Drugs & Chem. - Quaterly Results 3 Aug, 12:00 PM Par Drugs & Chem. - Quaterly Results 3 Aug, 12:00 PM Par Drugs & Chem. - Quaterly Results 3 Aug, 12:00 PM Par Drugs & Chem. - Quaterly Results 27 Apr, 12:00 PM Par Drugs & Chem. - Quaterly Results 27 Apr, 12:00 PM Par Drugs & Chem. - Quaterly Results 27 Apr, 12:00 PM Par Drugs & Chem. - Quaterly Results 10 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 10 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 10 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 9 Nov, 12:00 PM Par Drugs & Chem. - Quaterly Results 9 Nov, 12:00 PM Par Drugs & Chem. - Quaterly Results 28 Jul, 12:00 PM Par Drugs & Chem. - Quaterly Results 28 Jul, 12:00 PM Par Drugs & Chem. - Quaterly Results 7 May, 12:00 PM Par Drugs & Chem. - Quaterly Results 7 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 7 Feb, 12:00 PM Par Drugs & Chem. - Quaterly Results 7 Feb, 12:00 PM

Par Drugs & Chem. Stock Price Analysis and Quick Research Report. Is Par Drugs & Chem. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Par Drugs & Chem. stock price today is Rs 299.2. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Par Drugs & Chem. . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Par Drugs & Chem. has a PE ratio of 20.1530337320832 which is high and comparatively overvalued .

  • Share Price: - The current share price of Par Drugs & Chem. is Rs 299.2. One can use valuation calculators of ticker to know if Par Drugs & Chem. share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Par Drugs & Chem. has ROA of 15.2258 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Par Drugs & Chem. has a Current ratio of 4.7932 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Par Drugs & Chem. has a ROE of 18.4879 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Par Drugs & Chem. has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Par Drugs & Chem. has reported revenue growth of -0.1132 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Par Drugs & Chem. for the current financial year is 23.857595744058 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Par Drugs & Chem. is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Par Drugs & Chem. is Rs 14.8464 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Par Drugs & Chem. in Ticker for free. Also, one can get the intrinsic value of Par Drugs & Chem. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Par Drugs & Chem.
X